The 12-month price targets, analyzed by analysts, offer insights with an average target of $436.46, a high estimate of ...

Stryker, Smith+Nephew, J&J, and more had ortho innovation announcements at the American Academy of Orthopaedic Surgeons (AAOS ...

Valued at a market cap of $148.8 billion, Stryker Corporation (SYK) is a medical device company that operates in the orthopedic, neurotechnology & spine and surgical equipment markets. The Portage, ...

Those include augment and screw planning, intraoperative screw trajectory guidance and compatibility with Stryker’s revision ...

Stryker unveiled its updated Mako surgical robot and orthopedic companies expect procedure volumes to remain steady despite ...

Stryker remains a top-tier competitor in a number of attractive medical markets, including orthopedic implants, surgical instruments, endoscopy, and neurovascular devices. It enjoys a long record ...

Stryker (NYSE: SYK), a global leader in medical technologies, showcases the latest advancements in Mako SmartRobotics™ across ...

Stryker Co. (NYSE:SYK – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the twenty ratings ...

Stryker (NYSE:SYK – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “buy” rating to a “hold” rating in a research report issued to clients and investors on ...

Stryker Corporation is one of the largest global medical device companies with a focus on MedSurg, Neurotechnology, and Orthopaedics markets. The company has been a compounding ma ...

On Jan. 28, Stryker reported better-than-expected Q4 ... day after the company announced plans to sell its U.S. spinal implants business to Viscogliosi Brothers, LLC, a firm specializing in ...